Status:
UNKNOWN
Machine learnINg for the rElapse Risk eValuation in Acute Biliary Pancreatitis.
Lead Sponsor:
University of Cagliari
Collaborating Sponsors:
Università di Napoli Federico II
Università della Campania Luigi Vanvitelli
Conditions:
Acute Pancreatitis
Pancreatitis Due to Gallstones
Eligibility:
All Genders
18+ years
Brief Summary
The MINERVA (Machine learnINg for the rElapse Risk eValuation in Acute biliary pancreatitis) project stems from the need in the clinical practice of taking an operational decision in patients that are...
Detailed Description
Acute pancreatitis is the most common pancreatic disease, with a global incidence of 34 cases per 100,000 individuals. This disease counts more than 1.5 million new patients per year worldwide, with a...
Eligibility Criteria
Inclusion
- Adult patients (≥ 18 years old)
- Clinical diagnosis of mild biliary acute pancreatitis (according to the Revised Atlanta Classification)
- Not submitted to cholecystectomy or ERCP/ES (Endoscopic Retrograde CholangioPancreatography/Endoscopic Sphyncterotomy) during the same hospital admission
Exclusion
- Acute pancreatitis of etiology other than gallstones;
- Moderately-severe pancreatitis;
- Severe pancreatitis;
- Presence of pancreatic necrosis;
- Pregnant patients;
- Patients not able to sign the informed consent to take part in the study.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
430 Patients enrolled
Trial Details
Trial ID
NCT06124989
Start Date
January 1 2024
End Date
December 31 2025
Last Update
November 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Cagliari, Emergency Surgery Department
Cagliari, CA, Italy, 09120